Suppr超能文献

中药注射剂治疗类风湿关节炎的网络荟萃分析

[Network Meta-analysis of Chinese medicine injections in treatment of rheumatoid arthritis].

作者信息

Liu Shuo, Zhao Xi-Yun, Li Jin-Feng, Lu Zeng-Peng, Zhang Xiao-Gang

机构信息

Gansu University of Chinese Medicine Lanzhou 730000, China Affiliated Hospital of Gansu University of Chinese Medicine Lanzhou 730000, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2022 Oct;47(20):5627-5641. doi: 10.19540/j.cnki.cjcmm.20220727.501.

Abstract

This study aims to systematically evaluate the efficacy and safety of Chinese medicine injections in the treatment of rheumatoid arthritis. Specifically, randomized controlled trial(RCT) in the treatment of rheumatoid arthritis with Chinese medicine injections was retrieved from PubMed, EMbase, Cochrane Library, Web of Science, Wanfang, CNKI, VIP, and SinoMed(from inception to February 16, 2022). RevMan 5.3 and Stata 15.0 were employed for data analysis. Finally, 53 RCTs, involving 4 280 patients were included. The experimental groups involved the following injections: including Danshen Chuanxiongqin Injection, Tanshinone Ⅱ_A Sodium Sulfonate Injection, Danhong Injection, Dengzhan Xixin Injection, Gugua Extract Injection, Honghua Injection, Lugua Polypeptide Injection, Lugua Polypeptide Injection + Tanshinone Ⅱ_A Sodium Sulfonate Injection, Shuxuetong Injection, Zhengqing Fengtongning Injection, Compound Danshen Injection, and Xuebijing Injection. The network Meta-analysis showcased the following trends.(1) As for improving total clinical effective rate, the surface under the cumulative ranking curve(SUCRA) followed the order of conventional treatment of western medicine combined with Xuebijing Injection > combined with Gugua Extract Injection > combined with Compound Danshen Injection > combined with Danshen Chuanxiongqin Injection > combined with Honghua Injection > combined with Zhengqing Fengtongning Injection > combined with Danhong Injection > combined with Lugua Polypeptide Injection > combined with Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Dengzhan Xixin Injection.(2) As for improving erythrocyte sedimentation rate(ESR), SUCRA followed the order of conventional treatment of western medicine combined with Xuebijing Injection > combined with Shuxuetong Injection > combined with Honghua Injection > combined with Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Gugua Extract Injection > combined with Danhong Injection > combined with Lugua Polypeptide Injection > combined with Dengzhan Xixin Injection > combined with Lugua Polypeptide Injection + Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Danshen Chuanxiongqin Injection > combined with Zhengqing Fengtongning Injection.(3) As for improving rheumatoid factor(RF), SUCRA followed the order of conventional treatment of western medicine combined with Lugua Polypeptide Injection > combined with Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Lugua Polypeptide Injection + Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Gugua Extract Injection > combined with Danshen Chuanxiongqin Injection > combined with Zhengqing Fengtongning Injection > combined with Danhong Injection > combined with Dengzhan Xixin Injection.(4) As for improving C-reactive protein(CRP), SUCRA followed the order of conventional treatment of western medicine combined with Xuebijing Injection > combined with Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Lugua Polypeptide Injection + Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Honghua Injection > combined with Danshen Chuanxiongqin Injection > combined with Dengzhan Xixin Injection > combined with Gugua Extract Injection > combined with Lugua Polypeptide Injection > combined with Zhengqing Fengtongning Injection > combined with Danhong Injection.(5) As for alleviating morning stiffness, SUCRA followed the order of conventional treatment of western medicine combined with Shuxuetong Injection > combined with Lugua Polypeptide Injection > combined with Dengzhan Xixin Injection > combined with Xuebijing Injection > combined with Gugua Extract Injection > combined with Zhengqing Fengtongning Injection > combined with Danhong Injection > combined with Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Honghua Injection.(6) As for improving disease activity score(DAS28), SUCRA followed the order of conventional treatment of western medicine combined with Lugua Polypeptide Injection + Tanshinone Ⅱ_A Sodium Sulfonate Injection > combined with Lugua Polypeptide Injection > combined with Zhengqing Fengtongning Injection > combined with Honghua Injection > combined with Gugua Extract Injection > combined with Dengzhan Xixin Injection. The experimental groups had lower incidence of adverse reactions than the control group. The results of network Meta-analysis suggest that on the combination of conventional treatment of western medicine with Chinese medicine injections can improve the efficacy on rheumatoid arthritis. However, in view of the great differences in the quality and number of studies included for different therapies, the SUCRA of Chinese medicine injections need to be further verified with high-quality multi-center, large-sample, randomized double-blind trials.

摘要

本研究旨在系统评价中药注射剂治疗类风湿关节炎的有效性和安全性。具体而言,从PubMed、EMbase、Cochrane图书馆、Web of Science、万方、知网、维普和中国生物医学文献数据库(建库至2022年2月16日)中检索中药注射剂治疗类风湿关节炎的随机对照试验(RCT)。采用RevMan 5.3和Stata 15.0进行数据分析。最终,纳入53项RCT,涉及4280例患者。试验组涉及以下注射剂:包括丹参川芎嗪注射液、丹参酮ⅡA磺酸钠注射液、丹红注射液、灯盏细辛注射液、瓜蒌提取物注射液、红花注射液、鹿瓜多肽注射液、鹿瓜多肽注射液+丹参酮ⅡA磺酸钠注射液、舒血宁注射液、正清风痛宁注射液、复方丹参注射液和血必净注射液。网状Meta分析呈现以下趋势。(1) 在提高总临床有效率方面,累积排序曲线下面积(SUCRA)排序为:西药常规治疗联合血必净注射液>联合瓜蒌提取物注射液>联合复方丹参注射液>联合丹参川芎嗪注射液>联合红花注射液>联合正清风痛宁注射液>联合丹红注射液>联合鹿瓜多肽注射液>联合丹参酮ⅡA磺酸钠注射液>联合灯盏细辛注射液。(2) 在改善红细胞沉降率(ESR)方面,SUCRA排序为:西药常规治疗联合血必净注射液>联合舒血宁注射液>联合红花注射液>联合丹参酮ⅡA磺酸钠注射液>联合瓜蒌提取物注射液>联合丹红注射液>联合鹿瓜多肽注射液>联合灯盏细辛注射液>联合鹿瓜多肽注射液+丹参酮ⅡA磺酸钠注射液>联合丹参川芎嗪注射液>联合正清风痛宁注射液。(3) 在改善类风湿因子(RF)方面,SUCRA排序为:西药常规治疗联合鹿瓜多肽注射液>联合丹参酮ⅡA磺酸钠注射液>联合鹿瓜多肽注射液+丹参酮ⅡA磺酸钠注射液>联合瓜蒌提取物注射液>联合丹参川芎嗪注射液>联合正清风痛宁注射液>联合丹红注射液>联合灯盏细辛注射液。(4) 在改善C反应蛋白(CRP)方面,SUCRA排序为:西药常规治疗联合血必净注射液>联合丹参酮ⅡA磺酸钠注射液>联合鹿瓜多肽注射液+丹参酮ⅡA磺酸钠注射液>联合红花注射液>联合丹参川芎嗪注射液>联合灯盏细辛注射液>联合瓜蒌提取物注射液>联合鹿瓜多肽注射液>联合正清风痛宁注射液>联合丹红注射液。(5) 在缓解晨僵方面,SUCRA排序为:西药常规治疗联合舒血宁注射液>联合鹿瓜多肽注射液>联合灯盏细辛注射液>联合血必净注射液>联合瓜蒌提取物注射液>联合正清风痛宁注射液>联合丹红注射液>联合丹参酮ⅡA磺酸钠注射液>联合红花注射液。(6) 在改善疾病活动评分(DAS28)方面,SUCRA排序为:西药常规治疗联合鹿瓜多肽注射液+丹参酮ⅡA磺酸钠注射液>联合鹿瓜多肽注射液>联合正清风痛宁注射液>联合红花注射液>联合瓜蒌提取物注射液>联合灯盏细辛注射液。试验组不良反应发生率低于对照组。网状Meta分析结果提示,西药常规治疗联合中药注射剂可提高类风湿关节炎的疗效。然而,鉴于不同疗法纳入研究的质量和数量差异较大,中药注射剂的SUCRA结果需要高质量的多中心、大样本、随机双盲试验进一步验证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验